Janssen prima facie in contempt of STELARA injunction 01 Oct 2014Daniel Hynes After finding that Janssen’s STELARA products infringed AbbVie’s (formerly Abbott) Canadian Patent No. 2,365,281 (see here), Justice Hughes subsequently granted a permanent... Read More